Urinary Tract Infections in Kidney Transplant Recipients
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Neuromuscular Blockade on Shoulder Pain of Elderly
- Status
- COMPLETED
- Phase
- PHASE4
Vorapaxar on Thrombin Generation and Coagulability
- Status
- COMPLETED
- Phase
- PHASE4
Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair
- Status
- WITHDRAWN
- Phase
- NA
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Latency Reversal With High Dose Disulfiram Plus Vorinostat in HIV-infected Individuals on ART
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Optimisation of Follicular Recruitment in IVM Cycles
- Status
- COMPLETED
- Phase
- PHASE3
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sugammadex and Decreased Time to Extubation
- Status
- COMPLETED
- Phase
- PHASE4
SHOWME-PAD (Peripheral Artery Disease)
- Status
- COMPLETED
- Phase
- NA
Pembrolizumab for the Treatment of Recurrent High Grade Neuroendocrine Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)
- Status
- COMPLETED
- Phase
- PHASE3
Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)
- Status
- COMPLETED
- Phase
- PHASE1
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC
- Status
- TERMINATED
- Phase
- PHASE2
Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)
- Status
- COMPLETED
- Phase
- PHASE3
Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2